CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigate Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
35,156 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0097

Propionyl chloride CAS 79-03-8

Filed under Raw Materials. The bureau holds 123 laboratory returns for this compound from 39 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

39 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760A610.09.910.021 May 202621 May 2026
Tianjin Finder Chemical TFCCASE #VI-2026-0693A610.09.910.014 Nov 202516 Apr 2026
JEEP PeptidesCASE #VI-2026-0457A410.010.010.019 Dec 20258 Jul 2026
Mokemei BiotechnologyCASE #VI-2026-0540A410.09.910.028 Dec 20252 Jul 2026
Chinese Peptide CompanyCASE #VI-2026-0184A410.09.910.017 Apr 202615 Jul 2026
WuXi TIDESCASE #VI-2026-0335A410.010.010.025 Dec 202514 Jul 2026
Sigma-AldrichCASE #VI-2026-0829A410.09.910.03 Apr 20267 Aug 2026
Thermo Fisher ScientificCASE #VI-2026-0142A410.09.910.020 Apr 202618 Jul 2026
SinoPepCASE #VI-2026-0387A410.09.910.04 Mar 202626 Jun 2026
Hubei JianxiangCASE #VI-2026-0048A310.09.910.01 May 202613 Jul 2026
Shanghai Wibson BiotechnologyCASE #VI-2026-0379A310.09.910.014 Dec 20258 May 2026
BachemCASE #VI-2026-0314A210.010.010.08 Jan 202613 Jul 2026
Kerui PeptidesCASE #VI-2026-0626A210.010.010.014 Feb 202611 Mar 2026
Flourishglobal PeptideCASE #VI-2026-0630A49.99.99.97 Jan 202625 Jun 2026
GenScript PeptidesCASE #VI-2026-0860A49.99.910.018 May 202619 Jul 2026
AmbioPharmCASE #VI-2026-0177A49.99.910.027 Jan 20267 Jun 2026
Shanghai ERP BiotechnologyCASE #VI-2026-0936A39.99.910.016 Dec 20253 Jun 2026
AsymchemCASE #VI-2026-0091A39.99.910.04 Dec 202525 Jul 2026
Sangon BioCASE #VI-2026-0671A29.99.910.08 Dec 202520 Jun 2026
QYAOBIOCASE #VI-2026-0861A29.99.910.020 Jun 202628 Jun 2026
Shanghai Sigma AudleyCASE #VI-2026-0505A29.99.910.013 Jan 202627 Mar 2026
Hybio PharmaceuticalCASE #VI-2026-0065A29.99.910.028 Feb 202617 Mar 2026
PolyPeptide GroupCASE #VI-2026-0143A29.99.910.014 May 202612 Aug 2026
Liberty PeptidesCASE #VI-2026-0416X19.89.89.89 Jun 20259 Jun 2025
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284A59.18.310.023 May 202623 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594A68.76.610.023 May 202623 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486A38.68.09.321 May 202621 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704A58.46.79.921 May 202621 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538A58.27.88.625 May 202625 May 2026
Mai PeptideCASE #VI-2026-0769X17.17.17.111 Jun 202511 Jun 2025
ZLZ PeptideCASE #VI-2026-0524X76.74.38.613 Feb 202523 May 2026
Xingtai Jiachuang TechnologyCASE #VI-2026-0712X16.36.36.317 Dec 202417 Dec 2024
Xingruida XDRCASE #VI-2026-0898X46.24.57.113 Jun 202519 Jan 2026
Hunan Ruiwang Technology CenterCASE #VI-2026-0027X15.95.95.928 Mar 202528 Mar 2025
Astro PeptidesCASE #VI-2026-0424X25.84.96.813 Jun 202520 May 2026
Peptide CraftersCASE #VI-2026-0994X15.85.85.813 Feb 202513 Feb 2025
Yabang PeptideCASE #VI-2026-0148X13.93.93.924 Apr 202524 Apr 2025
PepLab SolutionsCASE #VI-2026-0431X10.60.60.627 Feb 202527 Feb 2025
PRIVATECASE #VI-2026-0635X10.00.00.02 Jul 20252 Jul 2025

Open any subject to view the batch-level evidence for Propionyl chloride CAS 79-03-8 alone.